Home Applications 217389 Application 217389
Type NDA
Sponsor MSD Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 OHTUVAYRE ENSIFENTRINE SUSPENSION;INHALATION 3MG/2.5ML Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N217389-001 OHTUVAYRE ENSIFENTRINE 3MG/2.5ML SUSPENSION / INHALATION RLD, RS 2024-06-26
Orange Book patents# Current patent rows page 1 of 1 · 5 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N217389-001 9062047 2031-08-21 U-3962 Drug substance 2024-07-12 N217389-001 10945950 2035-09-15 Drug product 2024-07-12 N217389-001 9956171 2035-09-15 U-3962 Drug product 2024-07-12 N217389-001 12409180 2043-02-20 Drug product 2025-10-07 N217389-001 12251384 2044-06-25 Drug product 2025-03-26
Orange Book exclusivity# Current exclusivity rows page 1 of 1 · 1 matching rows.
Application-product, Exclusivity code, Expiration table Application-product Exclusivity code Expiration N217389-001 NCE 2029-06-26
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N217389-001 OHTUVAYRE 3MG/2.5ML SUSPENSION / INHALATION RLD, RS 2024-06-26 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217389-001 OHTUVAYRE 3MG/2.5ML SUSPENSION / INHALATION RLD, RS 2024-06-26 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N217389-001 OHTUVAYRE 3MG/2.5ML SUSPENSION / INHALATION RLD, RS 2024-06-26 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217389-001 OHTUVAYRE 3MG/2.5ML SUSPENSION / INHALATION RLD, RS 2024-06-26 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217389-001 OHTUVAYRE 3MG/2.5ML SUSPENSION / INHALATION RLD, RS 2024-06-26 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N217389-001 OHTUVAYRE 3MG/2.5ML SUSPENSION / INHALATION RLD, RS 2024-06-26 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N217389-001 OHTUVAYRE 3MG/2.5ML SUSPENSION / INHALATION RLD, RS 2024-06-26 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N217389-001 OHTUVAYRE 3MG/2.5ML SUSPENSION / INHALATION RLD, RS 2024-06-26 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N217389-001 OHTUVAYRE 3MG/2.5ML SUSPENSION / INHALATION RLD, RS 2024-06-26 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N217389-001 OHTUVAYRE 3MG/2.5ML SUSPENSION / INHALATION RLD, RS 2024-06-26 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N217389-001 OHTUVAYRE 3MG/2.5ML SUSPENSION / INHALATION RLD, RS 2024-06-26 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N217389-001 OHTUVAYRE 3MG/2.5ML SUSPENSION / INHALATION RLD, RS 2024-06-26 301d65b070ca…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217389-001 OHTUVAYRE 3MG/2.5ML SUSPENSION / INHALATION RLD, RS 2024-06-26 a50c72e98297…
Observed Orange Book patent history# Patent history page 1 of 2 · 43 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-02-19 14:30 UTC 2026-02 N217389-001 9062047 2031-08-21 U-3962 Drug substance 2024-07-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217389-001 10945950 2035-09-15 Drug product 2024-07-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217389-001 9956171 2035-09-15 U-3962 Drug product 2024-07-12 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217389-001 12409180 2043-02-20 Drug product 2025-10-07 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N217389-001 12251384 2044-06-25 Drug product 2025-03-26 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217389-001 9062047 2031-08-21 U-3962 Drug substance 2024-07-12 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217389-001 10945950 2035-09-15 Drug product 2024-07-12 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217389-001 9956171 2035-09-15 U-3962 Drug product 2024-07-12 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217389-001 12409180 2043-02-20 Drug product 2025-10-07 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217389-001 12251384 2044-06-25 Drug product 2025-03-26 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N217389-001 9062047 2031-08-21 U-3962 Drug substance 2024-07-12 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217389-001 10945950 2035-09-15 Drug product 2024-07-12 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217389-001 9956171 2035-09-15 U-3962 Drug product 2024-07-12 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N217389-001 12251384 2044-06-25 Drug product 2025-03-26 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217389-001 9062047 2031-08-21 U-3962 Drug substance 2024-07-12 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217389-001 10945950 2035-09-15 Drug product 2024-07-12 fd3edfee7708…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217389-001 9956171 2035-09-15 U-3962 Drug product 2024-07-12 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217389-001 9062047 2031-08-21 U-3962 Drug substance 2024-07-12 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217389-001 10945950 2035-09-15 Drug product 2024-07-12 b8a1b40f171c…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217389-001 9956171 2035-09-15 U-3962 Drug product 2024-07-12 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N217389-001 9062047 2031-08-21 U-3962 Drug substance 2024-07-12 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N217389-001 10945950 2035-09-15 Drug product 2024-07-12 03ed91905a0d…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N217389-001 9956171 2035-09-15 U-3962 Drug product 2024-07-12 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N217389-001 9062047 2031-08-21 U-3962 Drug substance 2024-07-12 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N217389-001 10945950 2035-09-15 Drug product 2024-07-12 2680178bc6a6…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N217389-001 9956171 2035-09-15 U-3962 Drug product 2024-07-12 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N217389-001 9062047 2031-08-21 U-3962 Drug substance 2024-07-12 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N217389-001 10945950 2035-09-15 Drug product 2024-07-12 5bbf6a4d5a75…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N217389-001 9956171 2035-09-15 U-3962 Drug product 2024-07-12 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N217389-001 9062047 2031-08-21 U-3962 Drug substance 2024-07-12 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N217389-001 10945950 2035-09-15 Drug product 2024-07-12 d8e5a09893c0…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N217389-001 9956171 2035-09-15 U-3962 Drug product 2024-07-12 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N217389-001 9062047 2031-08-21 U-3962 Drug substance 2024-07-12 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N217389-001 10945950 2035-09-15 Drug product 2024-07-12 d06236e962d9…2024-10-29 15:01 UTC 2024-10 N217389-001 9956171 2035-09-15 U-3962 Drug product 2024-07-12 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N217389-001 9062047 2031-08-21 U-3962 Drug substance 2024-07-12 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N217389-001 10945950 2035-09-15 Drug product 2024-07-12 79d66fd596c7…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N217389-001 9956171 2035-09-15 U-3962 Drug product 2024-07-12 79d66fd596c7…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217389-001 9062047 2031-08-21 U-3962 Drug substance 2024-07-12 a50c72e98297…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217389-001 10945950 2035-09-15 Drug product 2024-07-12 a50c72e98297…
Observed Orange Book exclusivity history# Captured, Edition, Application-product table Captured Edition Application-product Exclusivity code Expiration Source SHA-256 2026-02-19 14:30 UTC 2026-02 N217389-001 NCE 2029-06-26 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N217389-001 NCE 2029-06-26 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N217389-001 NCE 2029-06-26 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N217389-001 NCE 2029-06-26 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N217389-001 NCE 2029-06-26 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N217389-001 NCE 2029-06-26 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N217389-001 NCE 2029-06-26 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N217389-001 NCE 2029-06-26 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N217389-001 NCE 2029-06-26 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N217389-001 NCE 2029-06-26 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N217389-001 NCE 2029-06-26 79d66fd596c7…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 N217389-001 NCE 2029-06-26 a50c72e98297…
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Ohtuvayre ENSIFENTRINE MERCK SHARP & DOHME LLC e6433c98-41a0-4f99-8f7f-d0e9db6e3f40 2026-04-23 Warnings, Adverse reactions Exact identifier application applno (NDA): 217389 application number: NDA217389
Documents# Document, Submission type, Date table Document Submission type Date 79127 ORIG 2024-07-22 78913 ORIG 2024-06-28 78916 ORIG 2024-06-27